Attorney Sees Chemours’ GenX Suit As Signal Of New TSCA ‘Pushback’

A lawyer focused on toxics issues says he sees the novel suit by chemical manufacturer Chemours over EPA’s per- and polyfluoroalkyl substances (PFAS) advisory levels as the start of a rise in “industry pushback” against TSCA rules and other chemical policies -- which could be boosted by the Supreme Court’s embrace of the “major questions” doctrine. John Gardella, a lawyer and shareholder with the Boston-based law firm CMBG3, tells Inside TSCA that EPA’s ramped-up efforts to study and address...